Two-Year trial tests new shot for Worn-Out knees

NCT ID NCT04520607

Summary

This study followed people with knee osteoarthritis to see if an experimental drug called lorecivivint was safe and helpful over two years. All 276 participants had been in a previous study and received injections into their knee. The goal was to see if the drug could reduce pain, improve knee function, and slow joint damage over the long term.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Tucson, Arizona, 85712, United States

  • Research Site

    Anaheim, California, 92805, United States

  • Research Site

    Pomona, California, 91767, United States

  • Research Site

    San Diego, California, 92103, United States

  • Research Site

    Thousand Oaks, California, 91360, United States

  • Research Site

    Denver, Colorado, 80209, United States

  • Research Site

    Hialeah, Florida, 33016, United States

  • Research Site

    Miami, Florida, 33173, United States

  • Research Site

    Miami Lakes, Florida, 33014, United States

  • Research Site

    Port Orange, Florida, 32127, United States

  • Research Site

    West Palm Beach, Florida, 33409, United States

  • Research Site

    Winter Haven, Florida, 33880, United States

  • Research Site

    Winter Park, Florida, 32789, United States

  • Research Site

    Newnan, Georgia, 30265, United States

  • Research Site

    Woodstock, Georgia, 30189, United States

  • Research Site

    Gurnee, Illinois, 60031, United States

  • Research Site

    Oak Brook, Illinois, 60523, United States

  • Research Site

    Valparaiso, Indiana, 46383, United States

  • Research Site

    New Orleans, Louisiana, 70124, United States

  • Research Site

    Bay City, Michigan, 48706, United States

  • Research Site

    Troy, Michigan, 48085, United States

  • Research Site

    Hazelwood, Missouri, 63042, United States

  • Research Site

    St Louis, Missouri, 63141, United States

  • Research Site

    Omaha, Nebraska, 68114, United States

  • Research Site

    Hartsdale, New York, 10530, United States

  • Research Site

    New York, New York, 10016, United States

  • Research Site

    Rochester, New York, 14609, United States

  • Research Site

    Charlotte, North Carolina, 28209, United States

  • Research Site

    Salisbury, North Carolina, 28144, United States

  • Research Site

    Winston-Salem, North Carolina, 27103, United States

  • Research Site

    Cincinnati, Ohio, 45242, United States

  • Research Site

    Columbus, Ohio, 43235, United States

  • Research Site

    Oklahoma City, Oklahoma, 73103, United States

  • Research Site

    Fort Mill, South Carolina, 29707, United States

  • Research Site

    Mt. Pleasant, South Carolina, 29464, United States

  • Research Site

    Rapid City, South Dakota, 57702, United States

  • Research Site

    Carrollton, Texas, 75007, United States

  • Research Site

    Plano, Texas, 75075, United States

  • Research Site

    San Antonio, Texas, 78229, United States

  • Research Site

    Draper, Utah, 84020, United States

  • Research Site

    Salt Lake City, Utah, 84107, United States

  • Research Site

    Charlottesville, Virginia, 22911, United States

Conditions

Explore the condition pages connected to this study.